Dr. Carter is CEO of Compliment Corp. He has founded five biotech companies in Seattle and worked for Corixa Corporation, now GSK Bio, where he led a new tuberculosis vaccine into human clinical trials. In 2004, he started and was the CEO of PAI Life Sciences, a bioinformatics company with proprietary drug discovery technology using artificial neural nets. This company has grants and contracts in the fields of biodefense, vaccines, drugs and diagnostics. In 2005 he co-founded Dharma Therapeutics Inc., a specialty pharmaceutical company focused on drug delivery where he worked as the Chief Scientific Officer (CSO) prior to its Japanese parent company going public in Singapore. In 2009 he help start a company focused on improving cancer outcomes, Compliment Corp. He is on the board of two Seattle biotechnology companies and acts as a scientific advisor for vaccine and global health institutes as well as having two affiliate appointments at the University of Washington in the School of Medicine and in Global Health. He is inventor on over 160 patents and patent applications and has authored over 60 publications. Darrick received his Ph.D. from Oregon Health and Science University and his B.S. from Oregon State University.